NYSE ARCA | ETF
Top 12 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 16.22% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 9.87% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 6.96% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 6.84% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 5.71% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 4.14% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 3.93% |
| OPCH | Option Care Health Inc | Healthcare | Medical Care Facilities | 3.7% |
| LNTH | Lantheus Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.94% |
| ICLR | ICON PLC | Healthcare | Diagnostics & Research | 2.9% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.87% |
| RCKT | Rocket Pharmaceuticals Inc | Healthcare | Biotechnology | 2.65% |
The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization. Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry ("health care companies"). It is non-diversified.